UK markets close in 7 hours 9 minutes

Celldex Therapeutics, Inc. (CLDX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
41.79+0.75 (+1.83%)
At close: 04:00PM EDT
41.79 -0.00 (-0.00%)
After hours: 04:04PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close41.04
Open41.33
Bid41.69 x 600
Ask41.80 x 200
Day's range40.66 - 42.36
52-week range22.11 - 53.18
Volume468,141
Avg. volume958,240
Market cap2.746B
Beta (5Y monthly)1.51
PE ratio (TTM)N/A
EPS (TTM)-2.92
Earnings date02 May 2024 - 06 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est70.71
  • Zacks

    Does Celldex (CLDX) Have the Potential to Rally 71.82% as Wall Street Analysts Expect?

    The consensus price target hints at a 71.8% upside potential for Celldex (CLDX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

  • GlobeNewswire

    Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma Conference

    HAMPTON, N.J., March 08, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the Leerink Partners Global Biopharma Conference on Monday, March 11, 2024 at 10:00 a.m. ET. A webcast of the presentation will be available on the "Events & Presentations” page of the "Investors & Media” section of the Celldex website. A replay will be available for 30 days following the event. About Celldex Therapeutics, Inc.Celldex i

  • GlobeNewswire

    Celldex Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference

    HAMPTON, N.J., March 05, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that Anthony S. Marucci, President and Chief Executive Officer will participate in an “Inflammation & Immunology Corporate Panel Discussion” at TD Cowen’s 44th Annual Health Care Conference. The panel will be held on Tuesday, March 5, 2024 from 2:10 to 3:10 PM ET. A live webcast of the panel discussion will be available on the investor section of the Celldex website. A replay of the webcast